Section 7: Regulation and Fibrinolysis Flashcards
Protein C is made where and dependent on what?
- Made in liver
- Vit K dependent
How is Protein C activated?
Thrombin-thrombomodulin complex attached to endothelium can activate Protein C
Protein C functions
- inactivate Va and VIIIa
- liberates tPA from endothelial cells
- Protein S is a cofactor
Protein S traits
- Vit K dependent
- Made in liver
- Non-proteolytic
Forms of Protein S
- 60% bound to C4b binding protein (complement protein)
- 40% free (this is the active form in coag)
Protein S function
Cofactor to Protein C
Protein Z traits
- Vit K dependent
- Made in liver
- Similar structure to other vit K dep factors except no activation site and non-proteolytic
Protein Z functions
- cofactor to Protein Z-Related Protease Inhibitor (ZPI)
- major role is to degrade Factor Xa
- need calcium + phospholipids
- slow-acting on its own
Protein Z-Related Protease Inhibitor (ZPI) traits
- vit K dep
- made in liver
ZPI functions
- cofactor to Protein Z
- action accelerated 1000-fold in presence of Protein Z
- major role is to degrade Factor Xa
- also degrades Factor XIa on its own
Antithrombin (AT, formerly ATIII) location made and function
- made in liver
- functions to form irreversible complex with Factors IIa, IXa, Xa, XIa, XIIa, and plasmin to slowly inactivate/neutralize them
Where is heparin found in the body?
Mast cells and tissue basophils
Heparin-like substances made by ___
Endothelial cells
Heparin cofactor II (HC-II) trait and functions
- made in liver
- function is specific to IIa neutralization/inactivation
- HC-II has accelerated activity in presence of heparin but less than AT
- present in platelets and may play role in thrombin regulation generated on plt surface
Tissue Factor Pathway Inhibitor (TFPI) functions
- low conc extrinsic pathway inhibitor
- ECs secrete TFPI into plasma
- TFPI inhibits Tissue Factor/Factor VIIA complex
List endogenous plasminogen activators
- Activated Protein C (APC)
- Urokinase
- XIIa and Kallikrein
List exogenous plasminogen activators
- tPA
- streptokinase
- urokinase
- recombinant tPA
Caveat to using exogenous plasminogen activators
They can break down pt’s fibrinogen (bad)
What happens to active plasmin that escapes the clot?
It gets destroyed by anti-plasmins
conc of plasmin in circulating plasma too low to achieve fibrinogenolysis
Plasmin functions
- lyses both fibrin and fibrinogen
- most plasmin activity occurs within the clot (fibrin major substrate)
- inactivates Va and VIIIa
- degrades XIIa into inactive fragments
Describe primary fibrinolysis (aka fibrinogenolysis)
- Plasmin cleaves fibrinogen into X and Y intermediate degradation products (FDP
- Plasmin further cleaves fibrinogen into D and E end products
Fibrinogen degradation product (FDP) functions
FDPs act as coag inhibitors by attaching to fibrin monomer and preventing polymerization and clot formation
Describe secondary fibrinolysis (fibrinolysis)
- Plasmin removes X and Y intermediates too
- Plasmin also cleaves fibrin into D and E end products
D-dimers
- Fibrin polymers are stabilized by XIIIa, which forms covalent bonds in the D domain to make an insoluble clot
- Plasmin breaking down fibrin clots results in D-dimers
T/F
D-dimers are present in both fibrinolysis and fibrinogenolysis
False
D-dimers present only in fibrinolysis
alpha2-antiplasmin
- made in liver
- functions to bind/inactivate free circulating plasmin that broke free from the clot
- rapid inhibitor that prevents lysis of fibrinogen or degradation of V and VIII
- not very effective at inactivating plasmin bound to fibrin
alpha2-macroglobulin
- not super great at its job but it works if alpha2-antiplasmin gets used up
- serves as slow plasmin inhibitor and prevents lysis of fibrinogen/degradation of V and VIII
Plasminogen Activator Inhibitors (PAI-1 and PAI-2)
- PAI-1 most important inhibitor to plasminogen activator system
- released from injured ECs and activated platelets
- function to neutralize/inactivate tPA and urokinase
Thrombin Activatable Fibrinolytic Inhibitor (TAFI)
- functions to alter fibrin clot so it’s less recognizable as a substrate for plasmin, thus it inhibits fibrinolysis
- activated by thrombin/thrombomodulin complex
- XIa enhances TAFI production
Consequences of Factor XIa deficiency in context of TAFI
Clot not modified -> increased fibrinolysis -> bleeding